Navigation Links
ADVENTRX and FDA Reach Agreement on Pivotal Study for ANX-514
Date:10/26/2011

itute one-third of the patients who receive Taxotere."  

About Study 514-02

Study 514-02 will be a randomized, open-label, multicenter, non-inferiority study comparing ANX-514, administered without corticosteroid premedication, and Taxotere, administered with corticosteroid premedication, in the treatment of non-small cell lung cancer after failure of prior platinum-based therapy.  Approximately 400 patients will be enrolled and treated until evidence of progressive disease, unacceptable toxicity, withdrawal of consent, or other withdrawal criteria are met.  The primary objective will be to compare the incidence of fluid retention between study arms.  The secondary objectives will be to compare ANX-514 and Taxotere in terms of overall safety profile, objective response rate, duration of response, progression-free survival and overall survival.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company focused on developing proprietary product candidates.  The Company's current lead product candidates are ANX-188, a novel, purified, rheologic and antithrombotic compound initially being developed as a first-in-class treatment for pediatric patients with sickle cell disease in acute crisis, and ANX-514, a detergent-free formulation of the blockbuster drug Taxotere®, which recently went off-patent.  The Company is seeking a partner or outside investor for its Exelbine program.  More information can be found on the Company's web site at www.adventrx.com.  

Forward Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on ADVENTRX's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding the design for,
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Pharmaceuticals to Present at the 10th Annual BIOInvestor Forum Conference on October 26
2. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12
3. ADVENTRX Provides Update on All Three Pipeline Products
4. ADVENTRX Reports Second Quarter 2011 Financial Results
5. ADVENTRX Pharmaceuticals to Present at the 31st Annual Canaccord Genuity Growth Conference on August 11
6. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
7. ADVENTRX Reports First Quarter 2011 Financial Results
8. ADVENTRX Completes Acquisition of SynthRx
9. ADVENTRX Pharmaceuticals Provides Update on ANX-514
10. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
11. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today announced ... Global Healthcare Conference in New York . ... at 11 a.m. Eastern Time. To listen to the live ... Investor Relations section of the Company,s Web site at ... after the event. About Orexigen® Therapeutics Orexigen ...
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ... SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting and ... will be held at the San Diego ... California , from May 20 - 22.  ... analytical system, incorporating commercial audio-visual technologies into new and ...
(Date:5/17/2013)... -- ConvaTec today announced that it will report its 2013 first quarter earnings ... and Ed Borkowski , CFO, will host an analyst ... To participate in the conference call within the U.S. and ... the conference call outside the U.S. and Canada , ... Participants should dial in 10 minutes prior to the start of ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... SAN FRANCISCO, Oct. 27 Astellas Pharma Inc. ("Astellas") ... that they have entered into a global agreement to ... treatment of prostate cancer. MDV3100 is currently being ... men with castration-resistant prostate cancer who were previously treated ...
... Oct. 27 Intercept Pharmaceuticals, Inc., today announced positive ... II clinical trial of INT-747 in patients with ... effects of adding one of three doses of INT-747 ... who did not respond adequately to UDCA therapy alone. ...
Cached Medicine Technology:Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer 2Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer 3Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer 4Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer 5Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer 6Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis 2Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis 3
(Date:5/19/2013)... Beach, Florida (PRWEB) May 19, 2013 ... and market access, is pleased to unveil a new ... show environment that provides a powerful array of real-time ... partners in the US and abroad. , HE-Xpo is ... will offer attendees the look and feel of being ...
(Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
(Date:5/18/2013)... 2013 Also known as bariatric ... weight loss surgery that guarantees patients long-term weight loss. ... wishes to give readers a brief tutorial on this ... school at New York City’s Mount Sinai School of ... undertook a fellowship in Minimally Invasive Bariatric Surgery. He ...
(Date:5/18/2013)... -- Just a few extra cups of coffee each ... liver disease known as primary sclerosing cholangitis (PSC), a ... in Rochester, Minn., found that drinking coffee was associated ... can lead to cirrhosis of the liver, liver failure ... a cause-and-effect relationship. "While rare, PSC has ...
(Date:5/18/2013)... 2013 In a May 14, 2013 ... Mastectomy After Discovering Cancer Gene,” Fox News reported the ... learning that she carried a gene that doctors estimated ... and a 50 percent risk of ovarian cancer (go ... May 16, 2013 with a blog post entitled “A ...
Breaking Medicine News(10 mins):Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2
... recognized that certain areas in the brain,s left hemisphere enable ... out exactly how those areas divvy up the highly complex ... brain imaging made within the last 10 years have revealed ... not only on particular regions of the cerebral cortex, but ...
... decades-long leadership in the area of palliative care, the ... one of the first nationwide to earn advanced certification ... accrediting body in health care. The commission,s Gold ... effective last month. The University,s program is only the ...
... David Eastmond at the University of California, Riverside ... Ramazzini , an organization of international scholars who work ... the world. Founded as an independent, international academy ... Ramazzini is comprised of a select group of no ...
... sex more often than women do, but a new study suggests ... and sleep, more frequently than women do, as well. And ... every seven seconds, which would amount to more than 8,000 thoughts ... number of young men,s thought about sex stood at almost 19 ...
... By Jenifer Goodwin HealthDay Reporter , ... children with attention-deficit/hyperactivity disorder (ADHD) show abnormalities in certain ... Researchers performed functional MRIs (fMRIs) on 19 children aged ... the disorder while the children took a test in ...
... 2011 - Serious global discussions have begun in the lead-up ... and international agencies are asking what has been achieved, what ... after the deadline. Against this backdrop, a new paper published ... finds that "quick impact" strategies, which may have solved some ...
Cached Medicine News:Health News:How the brain strings words into sentences 2Health News:How the brain strings words into sentences 3Health News:How the brain strings words into sentences 4Health News:Rochester's Palliative Care Program achieves top national certification 2Health News:Rochester's Palliative Care Program achieves top national certification 3Health News:Study debunks stereotype that men think about sex all day long 2Health News:Study debunks stereotype that men think about sex all day long 3Health News:Study debunks stereotype that men think about sex all day long 4Health News:Brain Pathways Seem Disrupted in Kids With ADHD 2Health News:Brain Pathways Seem Disrupted in Kids With ADHD 3Health News:Good intentions may hamper progress in pursuit of global reproductive health and rights 2
Bravo Tubing/Filter Supplies (Ten tubing sets, ten filters)...
... esophhageal sphincter (LES) can be ... separate manometry system. pH catheters ... accessory kit and Digitrapper pH ... the LES. The kit and ...
Buffer solution is needed to calibrate pH catheters. The specific chloride ion concentration in the Medtronic buffers is required for proper function of your Medtronic pH measurement system. Buffer s...
The WaveMax is one of the most flexible stainless steel stents due to its unique wave design and has the lowest effective profile, accommodating a 6F sheath up to 7 mm....
Medicine Products: